A recent study on signaling profiles in non-Hodgkin lymphomas suggested that basal STAT3 (pY705) levels were elevated in CLL cells relative to normal B cells, but the statistical significance was not indicated [19]. This evidence concerns the gene STAT3 and B-cell chronic lymphocytic leukemia.